Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients.
about
Mechanisms involved in the development of chemotherapy-induced neuropathyMechanisms of chemotherapy-induced behavioral toxicitiesPaclitaxel-induced epithelial damage and ectopic MMP-13 expression promotes neurotoxicity in zebrafishPaclitaxel-induced increase in mitochondrial volume mediates dysregulation of intracellular Ca2+ in putative nociceptive glabrous skin neurons from the ratPaclitaxel-induced painful neuropathy is associated with changes in mitochondrial bioenergetics, glycolysis, and an energy deficit in dorsal root ganglia neurons.Enhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathyPathophysiology of Chemotherapy-Induced Peripheral Neuropathy.Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy.The influence of chemotherapy-induced neurotoxicity on psychological distress and sleep disturbance in cancer patients.Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy.Subclinical peripheral neuropathy in patients with multiple myeloma before chemotherapy is correlated with decreased fingertip innervation densityPersistent mobility disability after neurotoxic chemotherapyPrevention of paclitaxel-induced allodynia by minocycline: Effect on loss of peripheral nerve fibers and infiltration of macrophages in rats.Pregabalin attenuates docetaxel-induced neuropathy in rats.Paclitaxel-induced hyposensitivity to nociceptive chemical stimulation in mice can be prevented by treatment with minocycline.Sensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons.A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapyVasodilatation in the rat dorsal hindpaw induced by activation of sensory neurons is reduced by paclitaxelChemotherapy-induced polyneuropathy. Part I. Pathophysiology.Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in ratsNatural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1Terminal arbor degeneration--a novel lesion produced by the antineoplastic agent paclitaxel.Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline.Neurosteroid 3α-androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptomsPaclitaxel induces acute pain via directly activating toll like receptor 4Nociceptor beta II, delta, and epsilon isoforms of PKC differentially mediate paclitaxel-induced spontaneous and evoked pain.Follow-up psychophysical studies in bortezomib-related chemoneuropathy patients.Anti-nociceptive effect of kinin B₁ and B₂ receptor antagonists on peripheral neuropathy induced by paclitaxel in mice.Effects of goshajinkigan, hachimijiogan, and rokumigan on mechanical allodynia induced by Paclitaxel in miceLysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice.Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy.Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat.Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy.Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction.Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cellsAcetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathyChemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit.Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin.Sensory neuron subpopulation-specific dysregulation of intracellular calcium in a rat model of chemotherapy-induced peripheral neuropathy.
P2860
Q26824380-D6AEBE9E-2833-430E-A54B-141DC4C7E34EQ26998870-527EEF55-BC67-4CB9-9CEE-7A407175CAFBQ27316580-4662C3FA-09A0-4237-A407-C671E87BF6F4Q29248252-A3326087-4091-4B43-AB5B-CD293FBA2AECQ30491771-FD4DD083-24FD-421E-B87F-F5A71E425957Q33650951-5AE7E27D-8E4A-4380-B78C-27B594A10DFCQ33744706-2999EE88-C215-43A9-9AF1-1FEB8FF37343Q33851825-02D9E555-F386-4F71-AED6-D0404402CEEBQ33982653-16ED9D26-48B5-4DDC-A516-ACEE50FCB371Q34038073-49936690-6D58-4586-8CD8-9F0CCFAB4C4EQ34226021-043071AB-BF55-4BF8-AAAB-3FB93FB66E74Q34259315-A39171B1-E106-4282-A919-10FC3025AEB3Q34347705-0BA80134-7709-4877-B965-EFA1B058D032Q34377508-CDF373CD-17CF-4AEA-8413-1761B86584BEQ34384978-8F058500-5CBF-44BB-9815-20BC91F18E1DQ34412078-B6F5F4F2-1247-4963-9721-4C3E3B2A2271Q34438547-0E417F79-CC2B-4DE7-AC0D-17ED9C8A1CE3Q34538185-F8502442-B383-4F24-A6AA-BDA71911CBA2Q34653461-0862BD74-E1C5-4010-9441-1DA51BE2CCA5Q34802605-D426681F-C734-4C02-8DFB-5693F956E80BQ34866427-E8610A19-543F-4300-9F61-94E43A9F3205Q34917256-423CB915-1975-4988-AB02-EC9E1DA1CF9DQ35000576-7352945E-728E-4ED8-A71F-B3953DC236BFQ35049356-12291A6C-BE46-47D1-8EA8-3A82A1DDC4E3Q35187300-3E189F5A-B1F3-4621-BBCD-199B8B9E273EQ35187458-71849AE3-D152-44EF-BF11-836CB9A8EA47Q35188312-3BDFFF8C-659C-426B-8744-B913CE9CF881Q35287537-5085F1AE-2A32-4E90-BDD9-EE4015E7F870Q35402526-74E50212-3AE5-4371-A0BE-C3B66D20FCC1Q35438322-E7F0D199-CFEA-4837-B8A2-A4DBAB465101Q35449249-5D50C225-E34D-4EB5-ACF7-F86CEC827CB2Q35613627-6F989A6A-0373-45A2-BA22-00E26988E5E8Q35651990-BEC9ECA3-6E8E-4520-BFB1-F21280BF6C7DQ35651995-1898F8DC-FB09-40C5-B550-D6BA52214F8AQ35652741-EDCEC166-17EA-4B74-A048-7A69F8A5DC3BQ35652799-6C4EEA36-049E-485C-8A4C-3DE6B3EA7436Q35652804-2093169B-9E5A-4BF6-9E6B-84020B5EB7A3Q35740234-862F9EBA-693F-4102-9795-99A579D1E6FAQ35784775-5D24CA00-CEF5-4CED-AC04-D0DC5A27C963Q35798221-DEA0773E-B8EF-43CD-988F-4E0935B28AA7
P2860
Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Taxol-induced sensory disturba ...... r function in cancer patients.
@en
Taxol-induced sensory disturba ...... r function in cancer patients.
@nl
type
label
Taxol-induced sensory disturba ...... r function in cancer patients.
@en
Taxol-induced sensory disturba ...... r function in cancer patients.
@nl
prefLabel
Taxol-induced sensory disturba ...... r function in cancer patients.
@en
Taxol-induced sensory disturba ...... r function in cancer patients.
@nl
P2093
P1433
P1476
Taxol-induced sensory disturba ...... r function in cancer patients.
@en
P2093
Allen Burton
Han-Rong Weng
Joseph V Cordella
Juan P Cata
P304
P356
10.1016/J.PAIN.2004.01.021
P407
P577
2004-05-01T00:00:00Z